News
Johnson & Johnson Announces Agreement in Principle with Government...
Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, has agreed in principle to supply the Government of Canada with doses of...
News
Thermo Fisher Scientific Officially Opens New Site for Manufacturing...
Thermo Fisher Scientific Inc., the world leader in serving science, officially cut the ribbon on its new $40 million facility in Lenexa, Kansas dedicated to...
News
CSafe Global Expands Further into Asia Opening Hub Operations...
CSafe Global, the innovation leader in temperature-controlled container solutions for the transport of life-enhancing pharmaceuticals, has once again expanded their global reach and local presence...
News
Stevanato Group signs an agreement with Nelson Labs to...
Italian-based Stevanato Group, a leading producer of glass primary packaging and provider of integrated services for combination products, and Nelson Laboratories, LLC, a global provider...
News
EU approves AstraZeneca’s Imfinzi for treatment of extensive-stage small...
AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union for the first-line treatment of adults with extensive-stage small cell lung cancer (ES-SCLC) in combination...
News
AstraZeneca begins Phase III trial of Covid-19 vaccine in...
AstraZeneca has expanded the clinical development of its potential Covid-19 vaccine candidate AZD1222 in the US, by initiating a Phase 3 clinical trial, dubbed D8110C00001.
The...
News
Sanofi provides update on Kevzara Phase 3 trial in...
Sanofi announced that the global Phase 3 trial investigating intravenously administered Kevzara® (sarilumab) at a dose of 200 mg or 400 mga in severely or...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.